포제 추출물을 포함하는 조성물
    271.
    发明公开
    포제 추출물을 포함하는 조성물 审中-实审
    含草药组合物的提取方法

    公开(公告)号:KR1020140049341A

    公开(公告)日:2014-04-25

    申请号:KR1020120115480

    申请日:2012-10-17

    Abstract: The present invention relates to a composition containing processed extracts, and more specifically, to a composition containing processed ginseng extracts and processed green tea extracts. According to one embodiment of the present invention, the composition includes processed ginseng extracts and processed green tea extracts as an active ingredient. According to another embodiment of the present invention, the composition suppresses and improves skin wrinkles.

    Abstract translation: 本发明涉及含有加工提取物的组合物,更具体地说,涉及含有加工的人参提取物和加工的绿茶提取物的组合物。 根据本发明的一个实施方案,组合物包括加工的人参提取物和加工的绿茶提取物作为活性成分。 根据本发明的另一个实施方案,组合物抑制并改善皮肤皱纹。

    꽃 쌈발효에 의한 항염증용 콩 추출물을 포함하는 조성물 및 제조방법
    274.
    发明公开
    꽃 쌈발효에 의한 항염증용 콩 추출물을 포함하는 조성물 및 제조방법 审中-实审
    含有大豆发酵的抗炎药组合物

    公开(公告)号:KR1020130120597A

    公开(公告)日:2013-11-05

    申请号:KR1020120043617

    申请日:2012-04-26

    CPC classification number: A61K36/48 A61K38/05

    Abstract: The present invention relates to an anti-inflammatory composition containing a soybean extract or a fraction thereof as an active ingredient, particularly, to a composition containing a soybean extract or a faction thereof containing 700 ug/g of dipeptides with anti-inflammation activities. A method for preparing the soybean extract comprises the steps of heating soybeans; fermenting the heated soybeans and flowers; and extracting the fermented soybeans.

    Abstract translation: 本发明涉及含有大豆提取物或其部分作为活性成分的抗炎组合物,特别涉及含有700μg/ g具有抗炎活性的二肽的大豆提取物或其组合物的组合物。 制备大豆提取物的方法包括加热大豆的步骤; 发酵加热的大豆和鲜花; 并提取发酵的大豆。

    녹차 종자 유래의 21-O-안젤로일데아사포젠올 E3 성분을 함유하는 항산화 또는 미백용 조성물
    275.
    发明公开
    녹차 종자 유래의 21-O-안젤로일데아사포젠올 E3 성분을 함유하는 항산화 또는 미백용 조성물 审中-实审
    含有来自绿茶种子的21-O-安格洛尔亚麻酚E3的抗氧化或白化的组合物

    公开(公告)号:KR1020130119212A

    公开(公告)日:2013-10-31

    申请号:KR1020120042191

    申请日:2012-04-23

    CPC classification number: A61K31/22 A61K36/82 A61K2236/19

    Abstract: PURPOSE: A composition for antioxidant or whitening effect containing 21-O-angeloyltheasapogenol E3 derived from green tea seed is provided to have an antioxidative effect by inhibition of DPPH and ROS production and an excellent whitening effect due to melanogenesis inhibition and an improvement of pigmentation by ultraviolet rays. CONSTITUTION: A composition for antioxidative skin external application contains 21-O-angeloyltheasapogenol E3 represented by the chemical formula 1 as an active ingredient. Per total weight of the composition, 0.0001-10 weight% of the 21-O-angeloyltheasapogenol E3 is contained. The 21-O-angeloyltheasapogenol E3 is derived from green tea seed. The 21-O-angeloyltheasapogenol E3 is obtained by degrading green tea seed extract using acid, base, enzymes, or microorganism producing the above enzyme.

    Abstract translation: 目的:提供含有来源于绿茶种子的21-O-异基因苦参因子E3的抗氧化剂或美白效果的组合物,通过抑制DPPH和ROS产生具有抗氧化作用,并且由于黑素生成抑制和色素沉着改善而具有优异的美白效果 紫外线。 构成:抗氧化皮肤外用组合物含有以化学式1表示的作为活性成分的21-O-神经酰基己内酯E3。 相对于组合物的总重量,含有0.0001-10重量%的21-O-对映异构基因组油E3。 21-O-对甲酰基己内酯E3衍生自绿茶种子。 通过使用产生上述酶的酸,碱,酶或微生物对绿茶种子提取物进行降解获得21-O-异基因苦参皂甙E3。

    프로토파낙사디올계 화합물을 포함하는 외용제 조성물
    277.
    发明公开
    프로토파낙사디올계 화합물을 포함하는 외용제 조성물 审中-实审
    用于外源应用的组合物包含原料基团化合物

    公开(公告)号:KR1020130117063A

    公开(公告)日:2013-10-25

    申请号:KR1020120039755

    申请日:2012-04-17

    Abstract: PURPOSE: An external use composition containing protopanaxadiol-based compounds is provided to effectively treat xerophthalmia compared with a conventional external use composition. CONSTITUTION: An external use composition for treating xerophthalmia contains 0.001-10 wt% of protopanaxadiol-based compounds as active ingredients. The compounds are compound K (20-O-(beta-D-glucopyranosyl)-20(S)-protopanaxadiol). An external use formulation includes transdermal preparation. The transdermal preparation includes a patch or a microneedle. [Reference numerals] (AA) Before using needle; (BB) After using needle

    Abstract translation: 目的:提供含有原人参二醇类化合物的外用组合物,与常规的外用组合物相比有效治疗干眼症。 构成:用于治疗干眼症的外用组合物含有0.001-10重量%的原人参二醇类化合物作为活性成分。 化合物为化合物K(20-O-(β-D-吡喃葡萄糖基)-20(S) - 原人参二醇)。 外用制剂包括透皮制剂。 透皮制剂包括贴片或微针。 (参考号)(AA)使用针前; (BB)使用针后

    콩뿌리 추출물을 함유하는 피부 외용제 조성물
    278.
    发明公开
    콩뿌리 추출물을 함유하는 피부 외용제 조성물 审中-实审
    含有大豆提取物的皮肤外用组合物

    公开(公告)号:KR1020130079220A

    公开(公告)日:2013-07-10

    申请号:KR1020120151679

    申请日:2012-12-24

    Abstract: PURPOSE: An external use skin composition containing a soybean root extract is improve antioxidation and antiaging abilities with skin moisturizing and whitening effects and to remove skin irritation using natural product-derived ingredients. CONSTITUTION: An external use skin composition contains a soybean root extract. The soybean root extract contains 0.12 wt% or more of coumestrol. Soybeans are used at V3-V4 step of growth and are treated with inducing factors. The inducing factors are selected from the group consisting of Aspergillus oryzae and chitosan. [Reference numerals] (AA) Content of coumestrol by each growth period; (BB) Coumestrol (mg/g); (CC) Soybean root extract

    Abstract translation: 目的:含有大豆根提取物的外用皮肤组合物可提高抗氧化和抗衰老能力,并具有皮肤保湿和美白效果,并使用天然产物衍生成分消除皮肤刺激。 构成:外用皮肤组合物含有大豆根提取物。 大豆根提取物含有0.12重量%以上的香豆素。 大豆在V3-V4生长阶段使用,并用诱导因子处理。 诱导因子选自米曲霉和壳聚糖。 (AA)每个生长期的香豆素的含量; (BB)辅酶A(mg / g); (CC)大豆根提取物

    피부 번들거림 평가법
    279.
    发明公开
    피부 번들거림 평가법 审中-实审
    确定皮肤光泽的方法

    公开(公告)号:KR1020130059666A

    公开(公告)日:2013-06-07

    申请号:KR1020110125746

    申请日:2011-11-29

    Abstract: PURPOSE: A skin gloss evaluating method is provided to closely compare an effect on a skin gloss with a result which is seen with the naked eye. CONSTITUTION: A formulation sample is coated on a skin. A surface reflection light image of the coated skin is photographed. A degree of a light intensity is analyzed from the photographed image. A light intensity sum of a light intensity domain is calculated in the analyzed result. A degree of a skin gloss is determined by the formulation sample through the light intensity sum.

    Abstract translation: 目的:提供一种皮肤光泽评估方法,以紧密比较对皮肤光泽的影响与用肉眼看到的结果。 构成:将制剂样品涂在皮肤上。 拍摄被覆皮肤的表面反射光图像。 从拍摄的图像分析光强度。 在分析结果中计算光强域的光强度和。 通过配方样品通过光强度和确定皮肤光泽度。

    안면 유형에 기초한 노화 진단 정보의 생성 방법 및 이를 이용한 노화 진단 방법
    280.
    发明公开
    안면 유형에 기초한 노화 진단 정보의 생성 방법 및 이를 이용한 노화 진단 방법 有权
    基于面类型生成老化测量信息的方法及其使用老化测量方法

    公开(公告)号:KR1020130058454A

    公开(公告)日:2013-06-04

    申请号:KR1020110124463

    申请日:2011-11-25

    CPC classification number: A61B5/1077 A61B5/1079 A61B5/441 G01B11/24

    Abstract: PURPOSE: An aging diagnosis information production method based on a face type and an aging diagnosis method using the same are provided to use three dimensional face data, thereby providing suitable beauty information. CONSTITUTION: Three dimensional face data for each experiment object is produced(S1). A position of a plurality of feature points is decided in the three dimensional face data(S2). Facial contour information is calculated in a line between the feature points(S3). A face type of each experiment object is determined by using the three dimensional face data(S4). The aging diagnosis information is decided by comparing the facial contour information(S5). [Reference numerals] (AA) Start; (BB) End; (S1) Produce three-dimensional face data for one or more first experiment objects belonging to a first aging group and one or more second experiment objects belonging to a second aging group; (S2) Determine a position of a feature point from the generated three-dimensional facial data; (S3) Calculate facial contour information related to a lint or a surface between feature points from each three-dimensional facial data; (S4) Determine a face type of a first experiment object and a second experiment object by using three-dimensional facial data; (S5) Determine aging diagnosis information by a face type after comparing facial contour information of an experiment object having the same face type of one or more first experiment objects and one or more second experiment objects

    Abstract translation: 目的:提供基于面部类型的老化诊断信息生成方法和使用其的老化诊断方法,以使用三维面部数据,从而提供合适的美容信息。 构成:产生每个实验对象的三维面部数据(S1)。 在三维人脸数据中决定多个特征点的位置(S2)。 在特征点之间的线中计算面部轮廓信息(S3)。 通过使用三维面部数据来确定每个实验对象的面部类型(S4)。 通过比较面部轮廓信息来决定老化诊断信息(S5)。 (附图标记)(AA)开始; (BB)结束; (S1)生成属于第一老化组的一个或多个第一实验对象和属于第二老化组的一个或多个第二实验对象的三维面部数据; (S2)从所生成的三维面部数据中确定特征点的位置; (S3)从每个三维面部数据计算与特征点之间的棉绒或表面相关的面部轮廓信息; (S4)通过使用三维面部数据来确定第一实验对象和第二实验对象的面部类型; (S5)在比较具有一个或多个第一实验对象的相同面部类型的实验对象的面部轮廓信息和一个或多个第二实验对象之后,通过面部类型来确定老化诊断信息

Patent Agency Ranking